Section Arrow
NERV.NASDAQ
- Minerva Neurosciences
Quotes are at least 15-min delayed:2026/04/18 04:13 EDT
Regular Hours
Last
 6.73
+0.44 (+7.00%)
Day High 
6.75 
Prev. Close
6.29 
1-M High
8.3828 
Volume 
265.50K 
Bid
6.3
Ask
7.3
Day Low
6.25 
Open
6.43 
1-M Low
5.02 
Market Cap 
272.20M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.67 
20-SMA 6.04 
50-SMA 6.35 
52-W High 12.46 
52-W Low 1.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-34.67/-0.48
Enterprise Value
272.20M
Balance Sheet
Book Value Per Share
-3.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.2572+0.0049+1.94%0.09PE
PBMPsyence Biomedical Ltd.7.6+1.73+29.47%-- 
GERNGeron Corp1.68-0.01-0.59%-- 
IBRXImmunityBio7.7+0.45+6.21%-- 
ADMAADMA Biologics11.01+0.27+2.51%17.92PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.